Product hub: Choosing the right tool for method screening and process optimisation
Posted: 28 November 2023 | European Pharmaceutical Review | No comments yet
CIM® Monolithic Well Plates combine the advantages of monolithic chromatography with the convenience of a standard well plate format. They ensure robustness and reliable results, making them ideal for screening multiple chromatographic conditions simultaneously.
Cell & Gene therapies and vaccines rely on the production of large biomolecules, such as virus particles, vesicles, RNAs, plasmids and other forms of DNA. These modalities are rather new, compared to established drug platforms like small-molecule therapies and monoclonal antibodies. As a result, their processes are still in the early stages and they have common requirements, such as the need for improved, easily scalable processes with reduced cost per dose and increased manufacturing yields. These advancements would accelerate the path to clinical trials and commercial availability. CIM® (convective interaction media) monolithic chromatography products were designed with unique operating properties that perfectly meet these challenging requests.
Related content from this organisation
- Quality from the start: designing a scalable AAV production platform
- European Pharmaceutical Review Issue 4 2024
- Application note: Equivalency of PCR-based rapid sterility testing and the compendial culture method
- Product hub: Choosing the right tool for method screening and process optimisation
- Microbial fermentation tech market to exceed $56.9b by 2033
Issue
Related topics
Antibodies, Biopharmaceuticals, Chromatography, Gene therapy, Ion Channel Drug Discovery, RNA, Vaccines, Viruses